217 related articles for article (PubMed ID: 22530244)
1. Promising new era dawns for cystic fibrosis treatment.
Corbyn Z
Lancet; 2012 Apr; 379(9825):1475-6. PubMed ID: 22530244
[No Abstract] [Full Text] [Related]
2. A new era in the treatment of cystic fibrosis.
Lane MA; Doe SJ
Clin Med (Lond); 2014 Feb; 14(1):76-8. PubMed ID: 24532752
[No Abstract] [Full Text] [Related]
3. Excitement mounts for first disease-modifying cystic fibrosis drugs.
Opar A
Nat Rev Drug Discov; 2011 Jul; 10(7):479-80. PubMed ID: 21720393
[No Abstract] [Full Text] [Related]
4. Cystic Fibrosis: The Dawn of a New Therapeutic Era.
Heltshe SL; Cogen J; Ramos KJ; Goss CH
Am J Respir Crit Care Med; 2017 Apr; 195(8):979-984. PubMed ID: 27710011
[No Abstract] [Full Text] [Related]
5. [Cystic Fibrosis: toward a genetic treatment; Clostridium difficile versus Clostridium difficile].
Nau JY
Rev Med Suisse; 2015 May; 11(476):1210-1. PubMed ID: 26182641
[No Abstract] [Full Text] [Related]
6. Cystic fibrosis transmembrane conductance regulator biomarkers in 'real life': can we evaluate individual efficacy of cystic fibrosis transmembrane conductance regulator therapy?
van Koningsbruggen-Rietschel S; Naehrlich L
Ther Adv Respir Dis; 2015 Aug; 9(4):198-200. PubMed ID: 26175480
[No Abstract] [Full Text] [Related]
7. Clinical trial research in focus: ensuring new cystic fibrosis drugs fulfil their potential.
Elborn JS; Davies J
Lancet Respir Med; 2017 Sep; 5(9):681-683. PubMed ID: 28853396
[No Abstract] [Full Text] [Related]
8. Targeting the basic defect in cystic fibrosis.
Welsh MJ
N Engl J Med; 2010 Nov; 363(21):2056-7. PubMed ID: 21083391
[No Abstract] [Full Text] [Related]
9. [FUTURE THERAPIES FOR CYSTIC FIBROSIS].
Fajac I
Rev Prat; 2015 Oct; 65(8):1106-8. PubMed ID: 26749719
[TBL] [Abstract][Full Text] [Related]
10. Ivacaftor in a G551D homozygote with cystic fibrosis.
Harrison MJ; Murphy DM; Plant BJ
N Engl J Med; 2013 Sep; 369(13):1280-2. PubMed ID: 24066763
[No Abstract] [Full Text] [Related]
11. Potentiators for cystic fibrosis - targeting the underlying molecular defect.
Patel S; Sinha IP; Dwan K; Echevarria C; Schechter M; Southern KW
Paediatr Respir Rev; 2015 Jun; 16(3):162-4. PubMed ID: 26002404
[No Abstract] [Full Text] [Related]
12. Remarkable progress toward new treatments for cystic fibrosis.
Eldredge LC; Ramsey BW
Lancet Respir Med; 2014 Dec; 2(12):962-4. PubMed ID: 25466347
[No Abstract] [Full Text] [Related]
13. Personalized medicine. New cystic fibrosis drug offers hope, at a price.
Kaiser J
Science; 2012 Feb; 335(6069):645. PubMed ID: 22323790
[No Abstract] [Full Text] [Related]
14. Intestinal Current Measurements Detect Activation of Mutant CFTR in Patients with Cystic Fibrosis with the G551D Mutation Treated with Ivacaftor.
Graeber SY; Hug MJ; Sommerburg O; Hirtz S; Hentschel J; Heinzmann A; Dopfer C; Schulz A; Mainz JG; Tümmler B; Mall MA
Am J Respir Crit Care Med; 2015 Nov; 192(10):1252-5. PubMed ID: 26568242
[No Abstract] [Full Text] [Related]
15. Carrier screening for cystic fibrosis in the new era of medications that restore CFTR function.
Massie J; Castellani C; Grody WW
Lancet; 2014 Mar; 383(9920):923-5. PubMed ID: 23992917
[No Abstract] [Full Text] [Related]
16. Cystic fibrosis--what are the prospects for a cure?
Kumar S; Tana A; Shankar A
Eur J Intern Med; 2014 Nov; 25(9):803-7. PubMed ID: 25447947
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic benefit of ivacaftor in late cystic fibrosis caused by homozygous IVS8-5T CFTR polymorphism.
Magne F; Durupt S; Nove-Josserand R; Bey-Omar F; Laoust L; Cottin V; Durieu I; Reynaud Q
J Cyst Fibros; 2017 Jan; 16(1):89-90. PubMed ID: 27810230
[No Abstract] [Full Text] [Related]
18. Treating Specific Variants Causing Cystic Fibrosis.
Cutting GR
JAMA; 2017 Dec; 318(21):2130-2131. PubMed ID: 29209709
[No Abstract] [Full Text] [Related]
19. A combination therapy for cystic fibrosis.
Brodsky JL; Frizzell RA
Cell; 2015 Sep; 163(1):17. PubMed ID: 26406363
[TBL] [Abstract][Full Text] [Related]
20. PharmGKB summary: ivacaftor pathway, pharmacokinetics/pharmacodynamics.
Fohner AE; McDonagh EM; Clancy JP; Whirl Carrillo M; Altman RB; Klein TE
Pharmacogenet Genomics; 2017 Jan; 27(1):39-42. PubMed ID: 27636560
[No Abstract] [Full Text] [Related]
[Next] [New Search]
